Literature DB >> 7406017

Consistent fluctuations in quantities of circulating immune complexes during progressive and regressive phases of tumor growth.

J C Jennette.   

Abstract

Circulating immune complexes (CIC) were quantitated by a Raji cell radioimmunoassay in sera from Brown Norway rats bearing progressing or regressing methylcholanthrene-induced sarcomas. Quantitative profiles of CIC over time were related to tumor dose, tumor mass, and the regressive or progressive course of tumor growth. Animals bearing progressing tumors demonstrated an initial peak of CIC levels by 7 weeks but thereafter displayed a persistent decline in quantities of CIC despite continued tumor growth. Animals bearing regressing tumors were found to have a more directly proportional relationship between the tumor mass and the levels of CIC, but the appearance and disappearance of CIC lagged slightly behind the appearance and disappearance of the tumor. These data are almost identical to data previously published detailing quantities of CIC in BN and Lewis rats bearing Moloney sarcomas and are similar to fluctuations in CIC observed in animals and humans hosting a number of disparate neoplasms.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7406017      PMCID: PMC1903543     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  14 in total

1.  Circulating immune complexes in patients with breast cancer.

Authors:  K Hoffken; I D Meredith; R A Robins; R W Baldwin; C J Davies; R W Blamey
Journal:  Br Med J       Date:  1977-07-23

2.  Brief communication: circulating antigen-antibody complex associated with Epstein-Barr virus in recurrent Burkitt's lymphoma.

Authors:  T Mukojima; P Gunvén; G Klein
Journal:  J Natl Cancer Inst       Date:  1973-10       Impact factor: 13.506

3.  Circulating immune complexes in human neuroblastoma: direct assay and role in blocking specific cellular immunity.

Authors:  D G Jose; R Seshadri
Journal:  Int J Cancer       Date:  1974-06-15       Impact factor: 7.396

4.  Binding of soluble immune complexes in serum of patients with Hodgkin's disease to tissue cultures derived from the tumor.

Authors:  J C Long; C L Hall; C A Brown; C Stamatos; S A Weitzman; K Carey
Journal:  N Engl J Med       Date:  1977-08-11       Impact factor: 91.245

5.  Sequential quantitation of circulating immune complexes in syngeneic and allogeneic rats bearing Moloney sarcomas.

Authors:  J C Jennette; J D Feldman
Journal:  J Immunol       Date:  1977-06       Impact factor: 5.422

6.  Circulating immune complexes in sera of patients with Burkett's lymphoma and nasopharyngeal carcinoma.

Authors:  R Heimer; G Klein
Journal:  Int J Cancer       Date:  1976-09-15       Impact factor: 7.396

7.  Immune complexes in cancer: demonstration of complexes in mice bearing neuroblastomas.

Authors:  M B Oldstone
Journal:  J Natl Cancer Inst       Date:  1975-01       Impact factor: 13.506

8.  The C1q binding test for soluble immune complexes: clinical correlations obtained in patients with cancer.

Authors:  R D Rossen; M A Reisberg; E M Hersh; J U Gutterman
Journal:  J Natl Cancer Inst       Date:  1977-05       Impact factor: 13.506

9.  Circulating immune complexes detected by 125I-Clq deviation test in sera of cancer patients.

Authors:  H Teshima; H Wanebo; C Pinsky; N K Day
Journal:  J Clin Invest       Date:  1977-06       Impact factor: 14.808

10.  Detection of circulating hepatoma D23 antigen and immune complexes in tumour bearer serum.

Authors:  R W Baldwin; J G Bowen; M R Price
Journal:  Br J Cancer       Date:  1973-07       Impact factor: 7.640

View more
  4 in total

1.  Immune complexes with antiglobulin activity in sera of Moloney sarcoma-bearing rats.

Authors:  J R Balint
Journal:  Clin Exp Immunol       Date:  1982-04       Impact factor: 4.330

2.  Circulating immune complexes (CIC), carcinoembryonic antigen (CEA) and CIC containing CEA as markers for colorectal cancer.

Authors:  K A Chester; R H Begent
Journal:  Clin Exp Immunol       Date:  1984-12       Impact factor: 4.330

3.  Adoptive T cell immunotherapy of MSV-induced tumours in nude mice. Part II. Sequential analysis of serum immune complexes and blocking activity in reconstituted mice in relation to tumour biology.

Authors:  D F Tucker; R A Knight; P H Warne
Journal:  Clin Exp Metastasis       Date:  1983 Jul-Sep       Impact factor: 5.150

4.  Circulating immune complexes as markers of response to chemotherapy in malignant teratomas and gestational trophoblastic tumours.

Authors:  R H Begent; K A Chester; L C Walker; D F Tucker
Journal:  Br J Cancer       Date:  1982-02       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.